Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB8 | P28062 | 2/20 | 0.46 |
| ▸ | CSNK1E | P49674 | 7/20 | 0.37 |
| ▸ | CSNK1G3 | Q9Y6M4 | 1/20 | 0.37 |
| ▸ | ATP4A | P20648 | 5/20 | 0.33 |
| ▸ | ATP4B | P51164 | 5/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.32 |
| ▸ | ATP1A1 | P05023 | 1/20 | 0.31 |
| ▸ | ATP1B1 | P05026 | 1/20 | 0.31 |
| ▸ | ATP1A3 | P13637 | 1/20 | 0.31 |
| ▸ | ATP1B2 | P14415 | 1/20 | 0.31 |
| ▸ | ATP1A2 | P50993 | 1/20 | 0.31 |
| ▸ | ATP1B3 | P54709 | 1/20 | 0.31 |
| ▸ | FXYD2 | P54710 | 1/20 | 0.31 |
| ▸ | ATP1A4 | Q13733 | 1/20 | 0.31 |
| ▸ | RET | P07949 | 1/20 | 0.30 |
| ▸ | RHEB | Q15382 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6994033 | 0.88 | PSMB8 (0.48) | PSMB8CSNK1ECSNK1G3ATP4AATP4B | |
| SCHEMBL10626657 | 0.73 | KDM4E (0.51) | CSNK1ECSNK1G3 | |
| Lithium Ion SCHEMBL29942329 | 0.73 | PSMB8 (0.54) | PSMB8RHEB | |
| SCHEMBL29935431 | 0.71 | PSMB8 (0.56) | PSMB8RHEB | |
| SCHEMBL29216479 | 0.69 | PSMB8 (0.54) | PSMB8RHEB | |
| Lithium SCHEMBL30899067 | 0.69 | PSMB8 (0.54) | PSMB8RHEB | |
| SCHEMBL10627035 | 0.69 | PSMB8 (0.64) | PSMB8RHEB | |
| SCHEMBL8560478 | 0.67 | CSNK1E (0.38) | CSNK1ECSNK1G3ATP4AATP4BNPY5R | |
| SCHEMBL1832199 | 0.67 | PSMB8 (0.65) | PSMB8 | |
| SCHEMBL15553070 | 0.66 | FABP6 (0.49) | CSNK1ECSNK1G3ATP4AATP4BNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0758334-B1 | SUBSTITUTED (1,4)DIOXINO(2,3-F)BENZOIMIDAZOLE DERIVATIVES AND THEIR USE IN PEST CONTROL | BAYER CROPSCIENCE AG (DE) | 2003-02-05 | — | — | EP | disclosed |
| US-20020026059-A1 | Benzimidazole derivatives | ASSMANN LUTZ (DE) | 2002-02-28 | — | — | US | disclosed |
| US-6235765-B1 | CONTROLLING DISEASES IN FRUITS, VEGETABLES; PRESERVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-05-22 | — | — | US | disclosed |
| US-6103745-A | USEFUL FOR HIGH FUNGICIDAL, INSECTICIDAL AND ACARICIDAL ACTIVITY | BAYER AKTIENGESELLSCHAFT (DE) | 2000-08-15 | — | — | US | disclosed |
| US-6090954-A | 2,3-DICHLORO-2,3-DIFLUORO-(1,4)-BENZODIOXANE, 2,3-DICHLORO-2,3-DIFLUORO-6,7-DINITRO-(1,4)-BENZODIOXANE, AND 6,7-DIAMINO-2,3-DICHLORO-2,3-DIFLUORO-(1,4)-BENZODIOXANE, AND PREPARATION; PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2000-07-18 | — | — | US | disclosed |
| US-6080776-A | USED AS A MICROBIOCIDE FOR CROP PROTECTION | BAYER AKTIENGESELLSCHAFT (DE) | 2000-06-27 | — | — | US | disclosed |
| US-5990316-A | Substituted (1,4)dioxino(2,3-F) 6,7-Dichloro-6,7-difluoro-2-trichloromethyl-[1,4]-dioxino-[2,3-f]-benzim idazole and their use in pest control | BAYER AKTIENGESELLSCHAFT (DE) | 1999-11-23 | — | — | US | disclosed |
| EP-0820457-A1 | BENZIMIDAZOLE DERIVATIVES | BAYER AG (DE) | 1998-01-28 | — | — | EP | disclosed |
| US-5648316-A | FUNGICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-07-15 | — | — | US | disclosed |
| EP-0758334-A1 | SUBSTITUTED (1,4)DIOXINO(2,3-F)BENZOIMIDAZOLE DERIVATIVES AND THEIR USE IN PEST CONTROL | BAYER AG (DE) | 1997-02-19 | — | — | EP | disclosed |
| WO-1996032395-A1 | BENZIMIDAZOLE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1996-10-17 | — | — | WO | disclosed |
| WO-1995029918-A1 | SUBSTITUTED (1,4)DIOXINO(2,3-F)BENZOIMIDAZOLE DERIVATIVES AND THEIR USE IN PEST CONTROL | BAYER AKTIENGESELLSCHAFT (DE) | 1995-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020026059-A1 | Benzimidazole derivatives | BAK1, XDH, ZFX | PSMB8 3533/4885CSNK1E 1476/4885CSNK1G3 1244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.